相似文献
1
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review.
Infect Dis Ther. 2023 Feb;12(2):343-365. doi: 10.1007/s40121-022-00750-5. Epub 2023 Jan 7.
2
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
Chest. 2017 Oct;152(4):800-809. doi: 10.1016/j.chest.2017.04.175. Epub 2017 May 5.
3
Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.
Ann Am Thorac Soc. 2017 Jul;14(7):1129-1138. doi: 10.1513/AnnalsATS.201609-731OC.
4
Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
BMC Infect Dis. 2017 Jun 15;17(1):432. doi: 10.1186/s12879-017-2532-4.
5
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01105-18. Print 2018 Oct.
6
Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015.
Surg Infect (Larchmt). 2019 Sep;20(6):492-498. doi: 10.1089/sur.2018.314. Epub 2019 May 8.
7
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
J Antimicrob Chemother. 2020 Mar 1;75(3):609-617. doi: 10.1093/jac/dkz511.
8
Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01947-20.
9
Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China.
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00072-18. Print 2018 Jul.
10
Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
J Cyst Fibros. 2019 Sep;18(5):714-720. doi: 10.1016/j.jcf.2019.05.013. Epub 2019 May 25.
引用本文的文献
1
Prevalence and epidemiologic features of nontuberculous mycobacteria causing persistent surgical site infections in Bangladesh.
IJID Reg. 2025 Jul 27;16:100714. doi: 10.1016/j.ijregi.2025.100714. eCollection 2025 Sep.
2
Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective.
J Clin Tuberc Other Mycobact Dis. 2025 Jul 26;41:100554. doi: 10.1016/j.jctube.2025.100554. eCollection 2025 Dec.
3
Activity of combinations of bactericidal and bacteriostatic compounds in -infected mice: an overview.
Front Microbiol. 2025 Aug 1;16:1616149. doi: 10.3389/fmicb.2025.1616149. eCollection 2025.
4
Early surgical intervention for extensive nontuberculous mycobacterial pulmonary disease.
IJTLD Open. 2025 Jul 9;2(7):412-419. doi: 10.5588/ijtldopen.25.0127. eCollection 2025 Jul.
5
Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria.
Antibiotics (Basel). 2025 Apr 4;14(4):381. doi: 10.3390/antibiotics14040381.
6
Clinical Characteristics of Nontuberculous Mycobacterial Positivity Occurring During Multidrug-Resistant Tuberculosis Treatment: A Retrospective Study.
Trop Med Infect Dis. 2025 Mar 20;10(3):83. doi: 10.3390/tropicalmed10030083.
7
Sanitary Waters: Is It Worth Looking for Mycobacteria?
Microorganisms. 2024 Sep 27;12(10):1953. doi: 10.3390/microorganisms12101953.
8
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0110324. doi: 10.1128/aac.01103-24. Epub 2024 Oct 1.
9
Refractory Cryptoglandular Perianal Abscess and Fistulas Due to Mycobacterium avium Infection in an Immunocompetent Adult.
Cureus. 2024 Aug 26;16(8):e67827. doi: 10.7759/cureus.67827. eCollection 2024 Aug.
10
Exploring the Chemical Space of Mycobacterial Oxidative Phosphorylation Inhibitors Using Molecular Modeling.
ChemMedChem. 2024 Nov 18;19(22):e202400303. doi: 10.1002/cmdc.202400303. Epub 2024 Sep 20.
本文引用的文献
1
Alternatives to Antibiotics against .
Antibiotics (Basel). 2022 Sep 28;11(10):1322. doi: 10.3390/antibiotics11101322.
2
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0040822. doi: 10.1128/aac.00408-22. Epub 2022 Aug 2.
3
Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
J Glob Antimicrob Resist. 2022 Sep;30:395-398. doi: 10.1016/j.jgar.2022.07.012. Epub 2022 Jul 18.
4
Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series.
Int J Infect Dis. 2022 Sep;122:953-956. doi: 10.1016/j.ijid.2022.06.061. Epub 2022 Jul 4.
5
Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success.
Open Forum Infect Dis. 2022 May 23;9(6):ofac028. doi: 10.1093/ofid/ofac028. eCollection 2022 Jun.
6
Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide.
BMJ Case Rep. 2021 Oct 28;14(10):e243979. doi: 10.1136/bcr-2021-243979.
7
efficacy of relebactam versus avibactam against complex.
Cell Surf. 2021 Oct 9;7:100064. doi: 10.1016/j.tcsw.2021.100064. eCollection 2021 Dec.
8
Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
J Clin Tuberc Other Mycobact Dis. 2021 Jul 14;24:100261. doi: 10.1016/j.jctube.2021.100261. eCollection 2021 Aug.
9
Treatment of Mycobacterium abscessus Pulmonary Disease.
Chest. 2022 Jan;161(1):64-75. doi: 10.1016/j.chest.2021.07.035. Epub 2021 Jul 24.
10
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China.
Int J Infect Dis. 2021 Aug;109:253-260. doi: 10.1016/j.ijid.2021.06.055. Epub 2021 Jul 1.
Zotero 插件